Switching over

The Consumers Health Forum has backed the new government policy allowing pharmacists to switch patient to approved biological medicines where appropriate. 

In releasing their position statement recently, the CHF has confirmed that it does not have a policy of automatic 'a' flagging and that any such recommendations would be made on a case-by-case basis. 

"Decisions regarding approval of biosimilars must be driven by sound science and within a robust regulatory framework. CHF expects robust policy and regulation will govern ‘a’ flagging of